ICD-10 Coding for Suprarenal Mass(D35.00, D35.01, D35.02, D44.10, E27.8)
Complete ICD-10-CM coding and documentation guide for Suprarenal Mass. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Suprarenal Mass
D35.00-D35.02Primary Range
Benign neoplasm of adrenal gland
Used for benign adrenal masses, specifying laterality.
Neoplasm of uncertain behavior of adrenal gland
Used when the behavior of the adrenal mass is indeterminate.
Other specified disorders of adrenal gland
Used for specified adrenal disorders like cysts or hyperplasia.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D35.00 | Benign neoplasm of unspecified adrenal gland | Use when the adrenal mass is confirmed benign but laterality is unspecified. |
|
| D35.01 | Benign neoplasm of right adrenal gland | Use when the benign mass is located in the right adrenal gland. |
|
| D35.02 | Benign neoplasm of left adrenal gland | Use when the benign mass is located in the left adrenal gland. |
|
| D44.10 | Neoplasm of uncertain behavior of adrenal gland | Use when imaging or histology is indeterminate. |
|
| E27.8 | Other specified disorders of adrenal gland | Use for specified adrenal disorders like cysts or hyperplasia. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for suprarenal mass
Essential facts and insights about Suprarenal Mass
Primary ICD-10-CM Codes for suprarenal mass
Decision Criteria
clinical Criteria
- Mass is homogeneous with HU ≤10
Applicable To
- Adrenal adenoma
Excludes
- Malignant neoplasm of adrenal gland (C74.-)
Clinical Validation Requirements
- Imaging showing homogeneous mass with HU ≤10
- Stable size over 1 year
Code-Specific Risks
- Risk of using when laterality is known
Coding Notes
- Ensure imaging supports benign nature.
D35.01 - Benign neoplasm of right adrenal gland
Use when the benign mass is located in the right adrenal gland.
Applicable To
- Right adrenal adenoma
Excludes
- Malignant neoplasm of adrenal gland (C74.-)
Clinical Validation Requirements
- Imaging showing homogeneous mass with HU ≤10
- Stable size over 1 year
Coding Notes
Ensure imaging supports benign nature.
D35.02 - Benign neoplasm of left adrenal gland
Use when the benign mass is located in the left adrenal gland.
Applicable To
- Left adrenal adenoma
Excludes
- Malignant neoplasm of adrenal gland (C74.-)
Clinical Validation Requirements
- Imaging showing homogeneous mass with HU ≤10
- Stable size over 1 year
Coding Notes
Ensure imaging supports benign nature.
D44.10 - Neoplasm of uncertain behavior of adrenal gland
Use when imaging or histology is indeterminate.
Applicable To
- Adrenal mass with indeterminate features
Excludes
- Benign neoplasm of adrenal gland (D35.0-)
Clinical Validation Requirements
- Imaging showing HU >10 but ≤20
- Heterogeneous enhancement
Coding Notes
Ensure follow-up plan is documented.
E27.8 - Other specified disorders of adrenal gland
Use for specified adrenal disorders like cysts or hyperplasia.
Applicable To
- Adrenal cyst
- Adrenal hyperplasia
Excludes
- Unspecified disorder of adrenal gland (E27.9)
Clinical Validation Requirements
- Biochemical evidence of MACS
- Unilateral hyperplasia
Coding Notes
Ensure specific disorder is documented.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Suprarenal Mass to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D35.00.
Impact
Clinical: May lead to incorrect treatment planning., Regulatory: Triggers coding audits., Financial: Potential for reduced reimbursement.
Mitigation Strategy
Always document laterality in clinical notes., Use templates that prompt for laterality.
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Triggers audits for unspecified coding., Data Quality: Reduces accuracy of clinical data.
Mitigation Strategy
Ensure documentation specifies laterality and behavior.
Impact
Using unspecified codes can trigger audits.
Mitigation Strategy
Ensure documentation supports specific code selection.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Suprarenal Mass, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Suprarenal Mass
Use these documentation templates to ensure complete and accurate documentation for Suprarenal Mass. These templates include all required elements for proper coding and billing.
Adrenal Mass Follow-Up
Specialty: EndocrinologyRequired Elements
- Size/Stability
- Imaging characteristics
- Hormonal status
- Follow-up plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Suprarenal Mass? Ask your questions below.